Friday, December 19, 2014

Pharmacy Executives Face Murder Charges in Meningitis Deaths

BOSTON — Two senior executives of a Massachusetts compounding pharmacy were charged Wednesday with racketeering and murder in the production of tainted drugs that killed 64 people and sickened hundreds of others across the country with fungal meningitis in the fall of 2012.
The United States attorney’s office here charged Barry J. Cadden, an owner of New England Compounding Center Inc. and the head pharmacist, and Glenn A. Chin, a supervisory pharmacist, with 25 acts of second-degree murder in seven states — Florida, Indiana, Maryland, Michigan, North Carolina, Tennessee and Virginia.
“Senior N.E.C.C. pharmacists knew that, despite the filthy conditions at N.E.C.C., the drugs that they made were not property tested for sterility,” said Carmen Ortiz, the United States attorney for Massachusetts.
In all, 14 people were charged in a 131-count indictment, many of them pharmacists at the company, which is now closed. The charges include mail fraud, conspiracy and violation of the Food, Drug and Cosmetic Act. Most were taken into custody at their homes early Wednesday, officials said.
Barry Cadden, an owner of the New England Compounding Center, in 2012. Credit Susan Walsh/Associated Press
Among those accused were members of the Conigliaro family of Massachusetts — Gregory, Douglas and Carla. The family founded the company in 1998 as part of a broader business organization that included a recycling firm.
Carla and Douglas Conigliaro, a husband and wife, were accused of transferring $33 million in assets to eight different bank accounts after the pharmacy went into bankruptcy and a court ordered all assets frozen. The couple pleaded not guilty.
David Meier, a lawyer for the couple, said his clients had done nothing wrong. “To the extent that there were transfers, they were all legal,” he said.
READ MORE:http://www.nytimes.com/2014/12/18/us/new-england-compounding-center-steroid-meningitis-arrests.html?&_r=0

No comments:

Post a Comment